Coeptis Therapeutics Holdings Inc. Common Stock
Symbol: COEP (NASDAQ)
16.69
▼ (-4.39%) -0.766
Company Description:
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
Key Stats
- Today's Open: $17.31
- Today's High: $17.675
- Today's Low: $16.34
- Today's Volume: 39.68K
- Yesterday Close: $17.46
- Yesterday High: $18.2499
- Yesterday Low: $16.56
- Yesterday Volume: 74.87K
- Last Min Volume: 0
- Last Min High: $16.694
- Last Min Low: $16.637
- Last Min VWAP: $0
Company Profile
- Name: Coeptis Therapeutics Holdings Inc. Common Stock
- Website: https://www.coeptistx.com
- Listed Date: 2022-10-31
- Location: WEXFORD, PA
- Market Status: Active
- CIK Number: 0001759186
- SIC Code: 6199
- SIC description: FINANCE SERVICES
- Market Cap: $84.16M
- Round Lot: 100
- Outstanding Shares: 4.82M
- Asset Type: CS
RECENT FILINGS FOR COEP
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-12 | S-4/A | View |
| 2025-09-02 | 144 | View |
| 2025-08-15 | 424B3 | View |
| 2025-08-15 | 424B3 | View |
| 2025-08-15 | 424B3 | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-11 | S-4/A | View |
| 2025-08-07 | D | View |
| 2025-06-26 | S-4 | View |
| 2025-06-03 | 10-K/A | View |
| 2025-05-15 | 424B3 | View |
| 2025-05-15 | 424B3 | View |
| 2025-05-15 | 424B3 | View |
| 2025-05-14 | 10-Q | View |
| 2025-04-28 | 424B3 | View |
| 2025-04-28 | 424B3 | View |
| 2025-04-28 | 424B3 | View |
| 2025-04-28 | 8-K | View |
| 2025-04-23 | 424B4 | View |
| 2025-04-21 | EFFECT | View |
Latest News on COEP